secwatch / observer
8-K filed July 30, 2024, 7:59 PM ET ticker EBS CIK 0001367644
leadership confidence high sentiment neutral materiality 0.50

Emergent BioSolutions EVP, General Counsel and Corporate Secretary Jennifer Fox resigns effective August 16, 2024

Emergent BioSolutions Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jennifer Fox

Executive Vice President External Affairs, General Counsel and Corporate Secretary
EBS · Emergent BioSolutions Inc.
Effective
2024-08-16
Filed
July 30, 2024, 7:59 PM ET
Emergent BioSolutions, Inc. (the “Company”) announced that Jennifer Fox is resigning as Executive Vice President External Affairs, General Counsel and Corporate Secretary of the Company to pursue an opportunity outside of the Company and will continue in her current role until August 16, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jennifer Fox departed as Executive Vice President External Affairs, General Counsel and Corporate Secretary at Emergent BioSolutions Inc..

Action
resigning
Role
Executive Vice President External Affairs, General Counsel and Corporate Secretary
Exact text from the filing
Emergent BioSolutions, Inc. (the “Company”) announced that Jennifer Fox is resigning as Executive Vice President External Affairs, General Counsel and Corporate Secretary of the Company to pursue an opportunity outside of the Company and will continue in her current role until August 16, 2024.
View on SEC.gov

Emergent BioSolutions Inc. filing history →

Source: SEC EDGAR
accession 0001367644-24-000130
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.